A Historic Mass Tort Opportunity
The COVID-19 pandemic led to the rushed global rollout of experimental mRNA vaccines and treatments like Remdesivir and Paxlovid — often mandated with little long-term safety data. Now, over 1.2 million adverse events have been reported globally, and tens of thousands of injury lawsuits are emerging.
1.2M+ Adverse Reports
Serious health incidents reported to VAERS, EudraVigilance, and WHO databases across heart, neurological, and autoimmune systems.
Multiple MDLs Forming
Litigation is accelerating as law firms seek vaccine-injured plaintiffs for emerging COVID mass tort actions in U.S. federal courts.
Underserved Demographics
Many injured Americans — especially young adults and veterans — have not yet been connected with legal representation.
